i On The Market - Daily Newsletter
Every trading day, be ready to attack the market instead of reacting to the market.
You will know where the key technical resistance and support levels are and what the market is likely to do next. iStock will arm you with a target list of stocks to buy and sell - right now - based on our exclusive, proprietary trading models.
You will also receive monthly ETF model portfolio and trend trader model portfolio
Two Week FREE Trial
Terms and Conditions
Opinion and Analysis
Nektar Therapeutics (NKTR) and Orexigen Therapeutics, Inc. (OREX) A Pair Of FDA Approval Options
Jun 03, 2014 12:38 PM |
iShares NASDAQ Biotechnology Index (ETF) (IBB): 3 Biotechs Up 132% In 2013 With Huge Upside Potential
Jul 16, 2013 02:47 PM |
Decent Monday Session
Dec 11, 2012 01:00 AM |
More Articles on OREX..
Orexigen Therapeutics to Present at the Bank of America Merrill Lynch Global Healthcare Conference
Sep 16, 2014 04:15 PM |
Takeda and Orexigen Announce FDA Approval of Contrave? (naltrexone HCI and bupropion HCI) Extended-release Tablets for Chronic Weight Management
Sep 11, 2014 07:00 AM |
Orexigen Therapeutics to Host Conference Call and Webcast At 8:30 AM Eastern Time September 11, 2014
Sep 10, 2014 07:46 PM |
More Press Releases on OREX..
Avg. Short Term
Avg. Long Term
Compare to S&P
Join Blog Network
| Copyright 2014 all rights reserved
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
. Advertisement partners
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.